Skip to content

Evommune EVMN Earnings per common share - basic (in dollars per share)

Earnings per common share - basic (in dollars per share) at other companies

Quantum Computing Inc. logo
Quantum Computing Inc.QUBT
-$0.02-115%
Rumble, Inc. logo
Rumble, Inc.RUM
-$0.12-1,100%
CHE
ChemedCHE
$4.85-1.2%
Avanos Medical logo
Avanos MedicalAVNS
$0.11-21.4%
REX American Resources logo
REX American ResourcesREX
$0.56+115%
Belden logo
BeldenBDC
$1.31+1.6%

Other financials

Income statement

See full
Revenue$1.6M+3.5%
Gross profit$961.1K+10.9%
Operating income-$682.8K-2,027%
Net income-$7.0M-5,414%
EPS (diluted)-$0.36-1,700%

Balance sheet

See full
Cash & equivalents$1.1M+401%
Total debt$2.0M
Total equity-$4.5M-3,048%
Total assets$7.2M

Cash flow

See full
Operating cash flow-$424.6K-341%
CapEx$1.0-99.8%
Free cash flow-$2.7M-4,996%

Valuation

See full
Market cap$848.59M+42.8%
Enterprise value$849.52M
P/S127.3×

Profitability

See full
Gross margin53.7%
Operating margin-30.7%
Net margin-90.1%

Returns & leverage

See full
Return on equity275.7%
Debt / equity1.4×
Current ratio1.2×

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's earnings per common share - basic (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evommune 's earnings per common share - basic (in dollars per share)?
Evommune (EVMN) reported earnings per common share - basic (in dollars per share) of -$0.36 in Q1 2026.
How has Evommune 's earnings per common share - basic (in dollars per share) changed year-over-year?
Evommune 's earnings per common share - basic (in dollars per share) decreased by 1700.0% year-over-year, from -$0.02 to -$0.36.
What does earnings per common share - basic (in dollars per share) mean?
Calculates the portion of a company's profit allocated to each outstanding share of common stock, excluding the dilutive effects of potential securities. This is a primary indicator of profitability on a per-share basis for existing common shareholders. It serves as a fundamental benchmark for evaluating historical earnings performance.